Nano X Imaging Ltd (NNOX)
8.365
-0.26
(-2.96%)
USD |
NASDAQ |
May 31, 16:00
8.34
-0.02
(-0.30%)
After-Hours: 20:00
Nano X Imaging Enterprise Value: 413.78M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 413.78M |
| May 30, 2024 | 428.52M |
| May 29, 2024 | 415.22M |
| May 28, 2024 | 421.00M |
| May 24, 2024 | 417.54M |
| May 23, 2024 | 426.78M |
| May 22, 2024 | 431.40M |
| May 21, 2024 | 451.05M |
| May 20, 2024 | 493.82M |
| May 17, 2024 | 496.71M |
| May 16, 2024 | 498.44M |
| May 15, 2024 | 544.09M |
| May 14, 2024 | 538.89M |
| May 13, 2024 | 521.56M |
| May 10, 2024 | 512.89M |
| May 09, 2024 | 512.89M |
| May 08, 2024 | 479.37M |
| May 07, 2024 | 491.51M |
| May 06, 2024 | 476.48M |
| May 03, 2024 | 470.32M |
| May 02, 2024 | 464.26M |
| May 01, 2024 | 459.63M |
| April 30, 2024 | 448.08M |
| April 29, 2024 | 449.23M |
| April 26, 2024 | 448.08M |
| Date | Value |
|---|---|
| April 25, 2024 | 445.77M |
| April 24, 2024 | 455.59M |
| April 23, 2024 | 468.30M |
| April 22, 2024 | 451.54M |
| April 19, 2024 | 427.28M |
| April 18, 2024 | 454.43M |
| April 17, 2024 | 470.61M |
| April 16, 2024 | 465.99M |
| April 15, 2024 | 457.32M |
| April 12, 2024 | 491.41M |
| April 11, 2024 | 537.63M |
| April 10, 2024 | 524.35M |
| April 09, 2024 | 549.77M |
| April 08, 2024 | 556.12M |
| April 05, 2024 | 540.52M |
| April 04, 2024 | 558.43M |
| April 03, 2024 | 557.86M |
| April 02, 2024 | 503.54M |
| April 01, 2024 | 527.23M |
| March 31, 2024 | 494.88M |
| March 28, 2024 | 485.60M |
| March 27, 2024 | 491.96M |
| March 26, 2024 | 449.78M |
| March 25, 2024 | 484.45M |
| March 22, 2024 | 468.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
195.21M
Minimum
Oct 30 2023
3.907B
Maximum
Jan 27 2021
811.08M
Average
564.72M
Median
Enterprise Value Benchmarks
| BioLine Rx Ltd | 40.64M |
| Galmed Pharmaceuticals Ltd | -10.42M |
| Compugen Ltd | 92.97M |
| Can Fite Biofarma Ltd | 2.855M |
| BiomX Inc | -15.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.24M |
| Revenue (Quarterly) | 2.553M |
| Total Expenses (Quarterly) | 15.68M |
| EPS Diluted (Quarterly) | -0.21 |
| Gross Profit Margin (Quarterly) | -80.45% |
| Profit Margin (Quarterly) | -479.5% |
| Earnings Yield | -12.79% |
| Normalized Earnings Yield | -11.21 |